Literature DB >> 16305859

Incomplete revascularization during OPCAB surgery is associated with reduced mid-term event-free survival.

Massimo Caputo1, Barnaby C Reeves, Chanaka Rajkaruna, Hazaim Awair, Gianni D Angelini.   

Abstract

BACKGROUND: The aim of this study was to compare early and mid-term outcome in patients undergoing off-pump coronary artery bypass surgery who have had complete revascularizations and incomplete revascularizations (IRs).
METHODS: Patient and operative data were collected prospectively for all patients who had off-pump coronary artery bypass surgery. Patients with multivessel disease were classified as having IR if the number of diseased coronary systems (left anterior descending coronary artery, circumflex and right coronary artery) exceeded the number of distal anastomoses. In-hospital outcomes, survival, and event-free survival were compared between patients with complete revascularization and IR using propensity scores to take account of differences in prognostic factors.
RESULTS: There were 1,479 off-pump coronary artery bypass surgery patients between April 1996 and December 2002 (30% of all coronary artery bypass graft patients), and 16.0% (237 patients) had IRs. Patients with IRs tended to be older and were female, had more extensive disease, worse dyspnea, a higher Parsonnet score, poorer ejection fraction, congestive cardiac failure, asthma or chronic obstructive airways disease, and previous cardiac surgery. The adjusted hazard ratio for patient survival with IRs versus complete revascularizations was 1.56 (95% confidence interval, 1.19 to 2.06; p = 0.001). Analyses for multiple time periods confirmed that IRs had a significantly increased risk of death, but also that the risk disappeared after the first 4 to 6 months of follow-up (p < 0.0001).
CONCLUSIONS: Compared with off-pump coronary artery bypass surgery patients with complete revascularizations, those with IRs have reduced survival, but only in the first 4 to 6 months after surgery. Patients' preoperative condition, rather than IR itself, may explain these findings because IRs should have mid-term as well as early effects.

Entities:  

Mesh:

Year:  2005        PMID: 16305859     DOI: 10.1016/j.athoracsur.2005.05.077

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Incomplete revascularization: what the surgeon needs to know.

Authors:  Dror B Leviner; Gianluca Torregrossa; John D Puskas
Journal:  Ann Cardiothorac Surg       Date:  2018-07

Review 2.  Impact of incomplete surgical revascularization on survival.

Authors:  Miguel Guerra; João Carlos Mota
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-28

3.  Early increase in myocardial perfusion after stem cell therapy in patients undergoing incomplete coronary artery bypass surgery.

Authors:  Luís Henrique Wolff Gowdak; Isolmar Tadeu Schettert; Carlos Eduardo Rochitte; Luiz Augusto Ferreira Lisboa; Luís Alberto Oliveira Dallan; Luiz Antônio Machado César; Sérgio Almeida de Oliveira; José Eduardo Krieger
Journal:  J Cardiovasc Transl Res       Date:  2011-02       Impact factor: 4.132

4.  Using pump for bypass surgery--on-off-on again?

Authors:  Jennifer H Edwards; David T Huang
Journal:  Crit Care       Date:  2010-09-16       Impact factor: 9.097

5.  Factors associated with early mortality in haemodialysis patients undergoing coronary artery bypass surgery.

Authors:  Deniz Çevirme; Taylan Adademir; Mehmet Aksüt; Tülay Örki; Kamil Cantürk Çakalağaoğlu; Mete Alp; Kaan Kirali
Journal:  Cardiovasc J Afr       Date:  2016-07-22       Impact factor: 1.167

6.  Modifiable risk factors remain significant causes of medium term mortality after first time Coronary artery bypass grafting.

Authors:  Babu Kunadian; Joel Dunning; Russell W J Millner
Journal:  J Cardiothorac Surg       Date:  2007-12-03       Impact factor: 1.637

Review 7.  Off-Pump Coronary Artery Bypass Grafting: 30 Years of Debate.

Authors:  Mario Gaudino; Gianni D Angelini; Charalambos Antoniades; Faisal Bakaeen; Umberto Benedetto; Antonio M Calafiore; Antonino Di Franco; Michele Di Mauro; Stephen E Fremes; Leonard N Girardi; David Glineur; Juan Grau; Guo-Wei He; Carlo Patrono; John D Puskas; Marc Ruel; Thomas A Schwann; Derrick Y Tam; James Tatoulis; Robert Tranbaugh; Michael Vallely; Marco A Zenati; Michael Mack; David P Taggart
Journal:  J Am Heart Assoc       Date:  2018-08-21       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.